rhIGF-I enhances functional recovery from sciatic crush. Time-course and dose-response study.
Contreras
P C
PC
Cephalon Inc., West Chester, Pennsylvania 19380.
Steffler
C
C
Vaught
J L
JL
D000818:Animals; D004305:Dose-Response Relationship, Drug; D006614:Hindlimb; D006801:Humans; D007334:Insulin-Like Growth Factor I / Q000494:pharmacology*; D051379:Mice; D009409:Nerve Crush; D009416:Nerve Regeneration / Q000187:drug effects*; D011994:Recombinant Proteins / Q000494:pharmacology; D012584:Sciatic Nerve / Q000166:cytology / Q000187:drug effects / Q000502:physiology*
D011994:Recombinant Proteins; D007334:Insulin-Like Growth Factor I